More Drugs Possibly Linked to Meningitis Outbreak

Report this content

Federal officials have warned that more injectable drugs manufactured at the New England Compounding Center (NECC) may be infected with a fungus that is suspected to be behind the nationwide meningitis outbreak.

The Food and Drug Administration (FDA) issued the warning in the wake of new reports of infection associated with two other products made at NECC. The FDA says on its website one case is linked to a steroid called triamcinolone acetonide, administered to a patient in an epidural. The other case reported involved cardioplegic solution, administered during heart-transplant surgery.

However, the agency has not confirmed that that the infections resulted from the company’s drugs or that these drugs were tainted.

The FDA’s statement does say the sterility of other injectables made by NECC is “of significant concern; and out of an abundance of caution, patients who received these products should be alerted to the potential risk of infection.” 

NECC has recalled all of its products, surrendered its operating license, and continues to cooperate with health investigators.

Out of the 14,000 people believed to have taken potentially tainted shots of the steroid methylprednisolone acetate for back and other joint pain, 19 people have died, according to the Centers for Disease Control. There are some 247 people who have tested positive for fungal meningitis so far.

If you or a loved one has been harmed by a dangerous drug, contact Sokolove Law today for a free legal consultation and to find out if a dangerous drug lawyer may be able to help you.

Tags: